|
The
Convergence Forum is an annual event created by life sciences leaders, for life
sciences leaders. A select group of 125 participants will gather on Cape Cod, June
10 - 12, 2010 to explore the forces shaping the future of biotech,
pharma, venture capital, healthcare, and medical devices.
Our
2009 speakers
included Genzyme CEO Henri Termeer; Harvard Pilgrim CEO Charlie Baker; David Altshuler of the Broad
Institute; Dov Goldstein of Aisling Capital; Michael Lytton of Biogen Idec; Beth Israel Deaconness CEO Paul Levy; and Yvonne
Greenstreet of GlaxoSmithKline.
We hope to see you next June on the Cape.
You can request an
invitation here.
|